These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV]. Lopez M Clin Ter; 2001; 152(3):203-6. PubMed ID: 11692542 [No Abstract] [Full Text] [Related]
8. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group. Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A; J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521 [TBL] [Abstract][Full Text] [Related]
9. [Periwinkle alkaloids. Treatment of Hodgkin's disease and leukemia]. Jacquillat C; Weil M Sem Ther; 1964; 40(6):395-400. PubMed ID: 5233529 [No Abstract] [Full Text] [Related]
10. Vinblastine treatment of Hodgkin's disease. Selected observations of vinca alkaloid dose schedules in man and animals. Lenhard RE; Owens AH; Owellen RJ Johns Hopkins Med J; 1974 Apr; 134(4):211-7. PubMed ID: 4821134 [No Abstract] [Full Text] [Related]
11. [Chemotherapy of generalized forms of lymphogranulomatosis with vinblastine and vincristine]. Danova LA Vopr Onkol; 1975; 21(7):43-8. PubMed ID: 1216789 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of Hodgkin's disease. Progress of chemotherapy]. Jacquillat C; Weil M Sem Ther; 1967; 43(6):377-81. PubMed ID: 5618020 [No Abstract] [Full Text] [Related]
13. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma]. Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685 [TBL] [Abstract][Full Text] [Related]
14. Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages? Andrieu JM; Colonna P J Clin Oncol; 1998 Jun; 16(6):2283. PubMed ID: 9626234 [No Abstract] [Full Text] [Related]
15. [Clinical experience with vinblastine and vincristine]. Cipriani D Cancro; 1968; 21():Suppl 6:185-9. PubMed ID: 5264169 [No Abstract] [Full Text] [Related]
16. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease. Piga A; Ambrosetti A; Todeschini G; Cetto G; Perona G; Cellerino R Cancer Treat Rep; 1984; 68(7-8):947-51. PubMed ID: 6204754 [TBL] [Abstract][Full Text] [Related]
17. Pediatric Hodgkin's disease. Oliapuram Jose B; Koerner P; Bertolone S; Patel CC; Spanos WJ; Paris KJ; Silverman CL; Yashar CM J Ky Med Assoc; 2004 Mar; 102(3):104-6. PubMed ID: 15067795 [TBL] [Abstract][Full Text] [Related]
18. Combined modality therapy in previously untreated patients with advanced Hodgkin's disease: A 24-year follow-up study. Salloum E; Doria R; Farber LR; Roberts KB; Cooper DL Cancer J Sci Am; 1995; 1(4):267-73. PubMed ID: 9166487 [TBL] [Abstract][Full Text] [Related]
19. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone. Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771 [TBL] [Abstract][Full Text] [Related]